Acesso livre
Acesso livre

Farmácia/Notícias da Indústria

Estudo randomizado | Vitamina D não previne diabetes tipo 2 em adultos de alto risco.

30 Mai, 2022 | 13:24h

Comunicado de imprensa: Vitamin D does not prevent type 2 diabetes in high risk adults, trial finds – BMJ

Estudo original: Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population – The BMJ

Editorial: Vitamin D and risk of type 2 diabetes – The BMJ

Estudo de coorte | Uso materno de analgésicos durante a gestação e desfechos adversos perinatais.

30 Mai, 2022 | 13:23h

Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: cohort study of 151 141 singleton pregnancies – BMJ Open

Comunicado de imprensa: Painkiller advice for pregnant women should always be followed, as use is linked to newborn problems – University of Aberdeen

Conteúdos relacionados:

Paracetamol use during pregnancy — a call for precautionary action – Nature Reviews Endocrinology

Editorial: Caution needed: paracetamol use in pregnancy – Nature Reviews Endocrinology

Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood – JAMA Psychiatry

Associations between paracetamol (acetaminophen) intake between 18 and 32 weeks gestation and neurocognitive outcomes in the child: A longitudinal cohort study – Pediatric and Perinatal Epidemiology

Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies – American Journal of Epidemiology

Covid-19: estudo mostra que a efetividade vacinal diminui mais rapidamente em pacientes oncológicos.

30 Mai, 2022 | 13:13h

Comentário: Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds – The BMJ

Estudo original: Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study – The Lancet Oncology

Editorial: COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties – The Lancet Oncology

Revisão sistemática de escopo | Motivos para a prescrição de antibióticos por tempo além do recomendado no ambiente hospitalar.

30 Mai, 2022 | 13:06h

Why we prescribe antibiotics for too long in the hospital setting: a systematic scoping review – Journal of Antimicrobial Chemotherapy

Estudo de coorte | Análise do uso de antieméticos após início de hormonioterapia.

30 Mai, 2022 | 12:49h

Analysis of Antiemetic Use After Initiation of Hormone Therapy – JAMA Network Open

Estudo de coorte | Proteção e queda da imunidade natural e híbrida ao SARS-CoV-2.

27 Mai, 2022 | 13:39h

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 – New England Journal of Medicine

Editorial: Audio Interview: Waning Immunity against Covid-19

 

Comentário no Twitter

 

Estudo de caso-controle e teste negativo: efetividade dos reforços vacinais homólogos e heterólogos contra a variante Ômicron da COVID-19.

27 Mai, 2022 | 13:38h

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron – New England Journal of Medicine

M-A | Tratamento do diabetes tipo 2 com tirzepatida, um agonista duplo do receptor de GIP/GLP-1.

27 Mai, 2022 | 13:13h

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis – Diabetologia

Conteúdos relacionados:

Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis – Nature Medicine

Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial – JAMA (link para o resumo – $ para o texto completo)

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Efetividade da CoronaVac em crianças de 3 a 5 anos durante o surto da variante Ômicron do SARS-CoV-2 no Chile.

26 Mai, 2022 | 13:24h

Effectiveness of CoronaVac in children 3 to 5 years during the SARS-CoV-2 Omicron outbreak in Chile – Nature Medicine

Estudo de coorte | Análise de diagnósticos neuropsiquiátricos após início do uso de montelucaste.

26 Mai, 2022 | 13:09h

Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation – JAMA Network Open

Conteúdos relacionados:

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis – U.S. Food & Drug Administration

Adverse drug reactions of montelukast in children and adults – Pharmacology Research & Perspectives

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.